A new kind of immune therapy has shown promise against the third most common blood cancer, multiple myeloma, researchers said Wednesday.
May 13, 2015
An article publishing online today in Brain: A Journal of Neurology has found that individual differences in brain structure could help to determine the risk for future drug addiction. The study found that occasional users ...
May 13, 2015
As the practice of genetically profiling patient tumors for clinical treatment decision making becomes more commonplace, a recent study from The University of Texas MD Anderson Cancer Center suggests that profiling normal ...
May 13, 2015
Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease -hepatitis B virus (HBV) or hepatitis C virus ...
May 13, 2015
Patients with operable stage I non-small cell lung cancer (NSCLC) could achieve better overall survival rates if treated with Stereotactic Ablative Radiotherapy (SABR) rather than the current standard of care—invasive surgery—according ...
May 13, 2015
